Iambic Therapeutics

Iambic Therapeutics is disrupting the therapeutics landscape with its unique AI-driven drug-discovery platform. Iambic has assembled a world-class team that unites pioneering AI experts and experienced drug hunters with strong track records of success in delivering clinically validated therapeutics. The Iambic platform has been demonstrated to deliver high-quality, differentiated therapeutics to clinic with unprecedented speed and across multiple target classes and mechanisms of action. The Iambic team is advancing an internal pipeline of clinical assets to address urgent unmet patient needs. Learn more about the Iambic team, platform, and pipeline at iambic.ai

Machine learning,artificial intelligence,drug discovery,catalysis,materials,sustainability,chemistry,biochemistry,pharmaceuticals,polymers,quantum mechanics,molecular simulation,batteries,and energy

Iambic therapeutics operates in the Biotechnology research industry.

Iambic therapeutics's revenue is 11m - 100m

Iambic therapeutics has 51 - 200 employees.